Knowledge of sentinel lymph node status improves accuracy when predicting melanoma mortality and selecting patients for adjuvant immunotherapy

J Eur Acad Dermatol Venereol. 2024 Jul;38(7):e638-e639. doi: 10.1111/jdv.19709. Epub 2023 Dec 26.

Serigne N Lo^{1

2}, Alexander H R Varey^{1

2

3}, Mary-Ann El Sharouni^{1

4

5}, Richard A Scolyer^{1

2

6

7

8}, John F Thompson^{1

2

8

9}

¹ Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.
² Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
³ Department of Plastic of Surgery, Westmead Hospital, Sydney, NSW, Australia.
⁴ Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
⁵ Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
⁶ Department of Tissue Oncology and Diagnostic Pathology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, NSW, Australia.
⁷ Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.
⁸ Faculty of Health and Medical Sciences, The University of Western Australia, Perth, WA, Australia.
⁹ Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.

No abstract available

Publication types